Germany’s Pharmaceutical and Biotechnology Strategy Seeks to Strengthen Domestic Research and Production
The German government is advancing a national pharmaceutical strategy and chemical-industry agenda aimed at making Germany a more resilient location for medical research and specialized production. Berlin is seeking to reduce vulnerabilities exposed by disrupted global supply chains while preserving high-value jobs and technologies in Europe.